# Renal Denervation in Refractory Hypertension

Study · id `cardio:ct-nct01560312` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01560312](<https://clinicaltrials.gov/study/NCT01560312>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01560312

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 106 participants.

## Technical summary

Registry record NCT01560312. Randomized; no masking; primary purpose treatment. Start 2011-10 (registry gives no type); primary completion 2014-02 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 106 participants (enrolled count; ClinicalTrials.gov record NCT01560312, source copy `cardio:ctgov-nct01560312-2019-02-01`, retrieved 2026-10-26)
- Start date: 2011-10 (registry gives no type) (ClinicalTrials.gov record NCT01560312, source copy `cardio:ctgov-nct01560312-2019-02-01`, retrieved 2026-10-26)
- Primary completion: 2014-02 (actual) (ClinicalTrials.gov record NCT01560312, source copy `cardio:ctgov-nct01560312-2019-02-01`, retrieved 2026-10-26)
- Completion: 2014-02 (actual) (ClinicalTrials.gov record NCT01560312, source copy `cardio:ctgov-nct01560312-2019-02-01`, retrieved 2026-10-26)
- Countries: Czechia (ClinicalTrials.gov record NCT01560312, source copy `cardio:ctgov-nct01560312-2019-02-01`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01560312-2019-02-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: Renal Denervation in Refractory Hypertension
- Acronym: PRAGUE-15
- Condition: Hypertension
- Condition: Resistant to Conventional Therapy
- Intervention (Device): Renal denervation (Symplicity® Catheter System™)
- Lead sponsor: Charles University, Czech Republic
- Lead sponsor class: OTHER
- Collaborator: General University Hospital, Prague
- Collaborator class: OTHER
- Collaborator: University Hospital Olomouc
- Collaborator class: OTHER
- Collaborator: Cardiocenter Podlesí, Trinec, Czech Republic
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Resistant hypertension (`cardio:resistant-hypertension`)
- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: Charles University, Czech Republic (`cardio:org-charles-university-czech-republic`)
- Registry lists this organization as a collaborator: General University Hospital, Prague (`cardio:org-general-university-hospital-prague`)
- Registry lists this organization as a collaborator: University Hospital Olomouc (`cardio:org-university-hospital-olomouc`)

## Provenance

Content hash: 60459f37eb32fdacb42792cf9830d076cbded8ed41ffd2147f564671b448d50a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
